A new study by Drs. Karl Jablonowski and Brian Hooker of Children’s Health Defense titled Increased Mortality Associated with 2-Month Old Infant Vaccinations, analyzed linked Louisiana Department of Health immunization and death registry data to evaluate whether routine two-month infant vaccinations (administered at 60–90 days of life) are associated with mortality in the subsequent month (90–120 days)
Using individual-level records from 1,225 infants who later died before age three, investigators compared infants vaccinated in the two-month window with those unvaccinated during the same period, while holding age-at-death constant.
Infants vaccinated at two months showed consistently higher odds of death in the following month, with statistically significant risk increases spanning individual vaccines, cumulative exposure, sex, race, and combination products.
Most alarming, infants who received all six recommended two-month vaccines had a 68 percent higher odds of death overall (OR = 1.68; p = 0.0043), with the risk surging to +68 percent in Black infants and +112 percent in female infants (OR = 2.12; p = 0.0083).
Mortality risk increased with cumulative vaccine exposure (dose–response)
A clear cumulative risk pattern emerged as more vaccines were administered at the 2-month visit:
- All five 2-month vaccines (DTaP, rotavirus, HIB, polio, and pneumococcal vaccines) compared to unvaccinated infants:
+60 percent (OR = 1.60; p = 0.0084 — statistically significant)
- All six recommended vaccines (DTaP, rotavirus, HIB, polio, pneumococcal, and HepB vaccines) compared to unvaccinated infants:
+68 percent (OR = 1.68; p = 0.0043 — statistically significant)
Subgroup analyses also showed even stronger cumulative effects:
- Black infants (6 vaccines): +68 percent (OR = 1.68; p = 0.0311 — statistically significant)
- Female infants (6 vaccines): +112 percent (OR = 2.12; p = 0.0083 — statistically significant)
This cumulative analysis—summarized in the paper’s abstract and Figure 6—represents one of the study’s central findings.
